Malignant Lung Neoplasm — Trials

Malignant Lung Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

11,125 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2,650
Recruiting: 1,432
Ph III recruiting: 179
Growth YoY: +7%
Industry share: 37%
Top sponsor: AstraZeneca
Termination share: 34.8%
Trials / 1,000 deaths: 20.1 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,491)

clinicaltrialsPublishedShowing 301–350 of 1,845 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05962021	Neoadjuvant Toripalimab for Non-squamous NSCLC With EGFR Mutation	unknown	Phase 2	126	Peking University People's HospitalOTHER	0	Aug 1, 2023	clinicaltrials
NCT05648955	Effect of an Oral Nutritional Supplement on Muscle Mass During Anticancer Treatment(ALLIES)	unknown	Early Phase 1	118	Nutricia ResearchINDUSTRY	1	Jul 28, 2023	clinicaltrials